📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Morphic Therapeutics

1.1 - Company Overview

Morphic Therapeutics Logo

Morphic Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of oral integrin therapies in development to treat serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer; developing treatments for patients with immunological, fibrotic, neoplastic, and vascular diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Morphic Therapeutics

Avila Therapeutics Logo

Avila Therapeutics

HQ: United States Website
  • Description: Provider of covalent drugs for viral infections, cancers, and autoimmune diseases, designing and developing targeted small-molecule therapies including AVL-181, a hepatitis C virus protease inhibitor; partnered with Sanofi-Aventis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Avila Therapeutics company profile →
Ariad Pharmaceuticals Logo

Ariad Pharmaceuticals

HQ: United States Website
  • Description: Provider of oncology medicines, focused on the discovery, development and commercialization of treatments for cancer patients, including Iclusig for certain types of leukemia targeting cancer cells with specific genetic mutations; based in Cambridge, Massachusetts.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ariad Pharmaceuticals company profile →
Dako Logo

Dako

HQ: Denmark Website
  • Description: Provider of reagents, instruments, and software for cancer diagnostics to hospital and research laboratories, offering pathology solutions including diagnostic antibodies, IHC/ISH and flow cytometry reagents; staining and image analysis instruments; molecular and companion diagnostics; and pharmacodiagnostic kits (pharmDx).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Dako company profile →
Nativis Logo

Nativis

HQ: United States Website
  • Description: Provider of therapeutic modalities in development for the treatment of serious disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nativis company profile →
Immunovia Logo

Immunovia

HQ: Sweden Website
  • Description: Provider of blood-based diagnostics for early detection of pancreatic cancer, conducting clinical trials and validation studies to ensure accuracy and reliability, and collaborating with medical institutions and research centers globally to validate its diagnostic tests and bring them to market.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Immunovia company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Morphic Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Morphic Therapeutics

2.2 - Growth funds investing in similar companies to Morphic Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Morphic Therapeutics

4.2 - Public trading comparable groups for Morphic Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Morphic Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Morphic Therapeutics

What does Morphic Therapeutics do?

Morphic Therapeutics is a provider of oral integrin therapies in development to treat serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer; developing treatments for patients with immunological, fibrotic, neoplastic, and vascular diseases.

Who are Morphic Therapeutics's competitors?

Morphic Therapeutics's competitors and similar companies include Avila Therapeutics, Ariad Pharmaceuticals, Dako, Nativis, and Immunovia.

Where is Morphic Therapeutics headquartered?

Morphic Therapeutics is headquartered in United States.

How many employees does Morphic Therapeutics have?

Morphic Therapeutics has 1,000 employees 🔒.

When was Morphic Therapeutics founded?

Morphic Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Morphic Therapeutics in?

Morphic Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Morphic Therapeutics

Who are the top strategic acquirers in Morphic Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Morphic Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Morphic Therapeutics?

Top strategic M&A buyers groups and sectors for Morphic Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Morphic Therapeutics's sector and industry vertical

Which are the top PE firms investing in Morphic Therapeutics's sector and industry vertical?

Top PE firms investing in Morphic Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Morphic Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Morphic Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Morphic Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Morphic Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Morphic Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Morphic Therapeutics?

The key public trading comparables and valuation benchmarks for Morphic Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Morphic Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Morphic Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Morphic Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Morphic Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Morphic Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Morphic Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Morphic Therapeutics

Launch login modal Launch register modal